IJR News — today's news from every sideElena Vasquez It's disappointing that court decisions like this undermine efforts to limit abortions at the federal level. Jared Kim Settling might avoid bigger court losses but it leaves the core issue of mail order access unresolved. Nicole Hardy It's frustrating that the administration seems unwilling to defend restrictions on these drugs. Sam Okafor The court ruling shows why we need stronger federal rules on mifepristone instead of leaving it to states. Elena Vasquez These pro life groups are right to push back since the court ruling keeps the pills too accessible. Dana Whitfield Pro-life voters backed Trump for concrete changes but this outcome shows limited progress on restricting these services. Sam Okafor Women in remote areas gain real options from keeping the pill accessible this way without extra clinic visits. Elena Vasquez If the reversal treatment lacks solid evidence, the state has every right to stop charities from promoting it to vulnerable women. Elena Vasquez The pro-life push makes sense given the court's ruling, but Trump needs concrete steps on the pill instead of delays. Chris Dalton Trump appointed the justices who ended Roe, yet these groups are right that federal action on mifepristone has fallen short. Jared Kim Trump's court picks are letting these abortion pills stay too accessible and that's a real failure on his part. Derek Foss The administration should listen to pro-life groups and stop letting the court keep these drugs so widely available. Priya Raman These groups have a point. The administration should act faster on the pill instead of letting courts set the pace. Derek Foss The administration needs to stop relying on courts and take direct steps against the abortion pill distribution. Tom Gallagher These pro-life groups have a point since the ruling keeps mifepristone too accessible under the current FDA rules. Chris Dalton The activists should give the administration some credit since the court made the final call here anyway. 
